Download (3249Kb) - D-Scholarship@Pitt - University of Pittsburgh

containing cross-conjugated trienes, see: (b) Spino, C.; Liu, G.; Tu, N.; Girard, S. J. Org.
Chem. 1994, 59, 5596. (c) Dion, A.; Dubé, P.; Spino, C. Org. Lett. 2005, 7, 5601.
91. Payne A. D.; Willis A. C.; Sherburn M. S. J. Am. Chem. Soc. 2005, 127, 12188.
92. King, F. D. “Strategy and Tactics in Drug Discovery”, In Medicinal Chemistry: Principles
and Practice, 2 nd Edition, King F. D. Eds.; The Royal Society of Chemistry, Cambridge,
UK, 2002, pp 342-346.
93. See Comprehensive Organic Transformations. A Guide to Functional Group Preparations,
2 nd Edition. Richard C. Larock, pp.1870.
94. Yeung, Y. -Y.; Hong, S.; Corey, E. J. J. Am. Chem. Soc. 2006, 128, 6310.
95. Serna, S.; Tellitu, I.; Dominguez, A.; Moreno, I.; SanMartin, R. Org. Lett. 2005, 7, 3073.
96. Grimaldi, J.; Cormons, A. Tetrahedron Lett. 1986, 27, 5089.
97. Hu, T.; Li, C. Org. Lett. 2005, 7, 2035.
98. (a) Golden, J. E.; Aubé, J. Angew. Chem. Int. Ed. 2002, 41, 4316. (b) Sharghi, H.; Hosseini,
M. Synthesis, 2002, 1057.
99. For examples of γ-lactam formation via ring-closing metathesis, see: (a) Clayden, J.; Tunbull,
A.; Pinto, I. Tetrahedron: Asymmetry 2005, 16, 2235. (b) Badorrey, Cativiela, C.; Diaz-de-
Villegaz, M. D.; Diez, R.; Galvez, J. A. Tetrahedron Lett. 2004, 45, 719. For an example of
δ-lactam formation via ring-closing metathesis, see: (c) Niida, A.; Tomita, K.; Mizumoto,
M.; Tanigaki, H.; Terada, T.; Oishi, S.; Otaka, A.; Inui, K.; Fujii, N. Org. Lett. 2006, 8,
613.
100. (a) Xie, X.; Lu, X. Tetrahedron Lett. 1999, 40, 8415. (b) Xie, X.; Lu X.; Liu, Y.; Xu, W. J.
Org. Chem. 2001, 66, 6545.
101. Lei, A.; Waldkirch, J. P.; He, M.; Zhang, X. Angew. Chem. Int., Ed. 2002, 41, 4526.
319